Preparation and administration form comprising an acid-labile active compound

1. An administration form for pantoprazole sodium sesquihydrate, comprising pharmaceutical excipients and multiple individual active compound units comprising pantoprazole sodium sesquihydrate,

wherein the pantoprazole sodium sesquihydrate is present in the individual active compound units in a matrix made of a mixture comprising at least one fatty alcohol that is a linear, saturated or unsaturated primary alcohol having 10-30 carbon atoms and at least one solid paraffin, and

wherein said individual active compound units are solidified drops.

2. The administration form as claimed in claim 1 , wherein, in the mixture, one or more further excipients, selected from the group consisting of polymers, sterols and basic compounds, is/are present in the individual active compound units.

3. The administration form as claimed in claim 2 , wherein the polymer is selected from the group consisting of povidone, vinylpyrrolidone/vinyl acetate copolymer, polyvinyl acetate, cellulose ethers, cellulose esters, methacrylic acid/methyl methacrylate copolymer, methacrylic acid/ethyl methacrylate copolymer and mixtures thereof.

4. The administration form as claim in claim 2 , wherein the sterol is selected from the group consisting of ergosterol, stigmasterol, sitosterol, brassicasterol, campesterol, cholesterol, lanosterol and mixtures thereof.

5. The administration form as claimed in claim 2 , wherein the basic compounds are inorganic basic salts, amines or fatty amines.

6. The administration form as claimed in claim 1 , selected from the group consisting of suspensions, gels, tablets, coated tablets, multicomponent tablets, effervescent tablets, rapidly disintegrating tablets, powders in sachets, sugar-coated tablets, capsules and suppositories.

7. The administration form as claimed in claim 1 , wherein the solidified drops have a particle size range of 50-800 μm.

8. The administration form as claimed in claim 1 , wherein the solidified drops have a particle size range of 50-400 μm.

9. The administration form as claimed in claim 8 , wherein the solidified drops have a particle size range of 50-200 μm.

10. The administration form as claimed in claim 1 , wherein the fatty alcohol that is a linear, saturated or unsaturated primary alcohol having 10-30 carbon atoms is selected from the group consisting of cetyl alcohol, myristyl alcohol, lauryl alcohol, stearyl alcohol and mixtures thereof.

11. The administration form as claimed in claim 1 , wherein the solid paraffin is paraffinum solidum or ozocerite.

12. The administration form as claimed in claim 5 , wherein the inorganic basic salts are selected from the group consisting of ammonium carbonate and sodium carbonate.

13. The administration form as claimed in claim 5 , wherein the amines are selected from the group consisting of meglumine, di- or triethylamine and TRIS (2-amino-2-hydroxymethyl-1,3-propandiol).

14. The administration form as claimed in claim 5 , wherein the fatty amine is stearylamine.

15. A process for the production of an active compound unit in the form of a solidified drop comprising pantoprazole sodium sesquihydrate wherein the pantoprazole sodium sesquihydrate is present in the solidified drop in a matrix comprising at least one fatty alcohol that is a linear, saturated or unsaturated primary alcohol having 10-30 carbon atoms, comprising producing drops of a solution or dispersion of the pantoprazole sodium sesquihydrate in at least one fatty alcohol that is a linear, saturated or unsaturated primary alcohol having 10-30 carbon atoms by means of vibrating nozzles and solidifying the drops formed in a suitable medium.

16. A solidified drop prepared by the process as claimed in claim 15 .